News & Updates

Show Multimedia Only

Rheumatology patients must undergo screening for anxiety, depression, FM: study

10 Jun 2026

A significant proportion of rheumatology patients have been diagnosed with anxiety, depression, or fibromyalgia (FM), reveals a study, noting the importance of including screening for clinical decisions at all routine encounters.

Rheumatology patients must undergo screening for anxiety, depression, FM: study

10 Jun 2026

Heavy alcohol consumption raises CRC risk

10 Jun 2026 by

Individuals with high alcohol consumption are at increased risk of colorectal cancer (CRC), reports a study, which shows that alcohol intake may trigger colorectal carcinogenesis through mechanisms operating across major molecular pathways for CRC.

Heavy alcohol consumption raises CRC risk

10 Jun 2026

$TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients$

TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients

10 Jun 2026

Patients with radiographic axial spondyloarthritis (r-axSpA) who have been exposed to tumour necrosis factor inhibitor (TNFi) and interleukin (IL)-17 inhibitor (IL-17i) appear to have a lower risk of osteoporosis, but not hip fracture, than biologic disease-modifying antirheumatic drug (bDMARD)-naïve individuals, a recent study has shown.

TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients

10 Jun 2026

LNF-based regimens may alter trajectory of CHD treatment

10 Jun 2026 by

Individuals with chronic hepatitis D (CHD) may benefit from lonafarnib boosted with ritonavir (LNF/RTV) alone or in combination with peg-interferon-alfa (PEG), findings from the phase III D-LIVR trial have shown.

LNF-based regimens may alter trajectory of CHD treatment

10 Jun 2026

$Lutikizumab shows promise in refractory hidradenitis suppurativa$

Lutikizumab shows promise in refractory hidradenitis suppurativa

10 Jun 2026

Treatment with lutikizumab appears to improve outcomes in patients with moderate-to-severe hidradenitis suppurativa (HS) who have not responded to anti-TNF therapy, according to a phase II trial.

Lutikizumab shows promise in refractory hidradenitis suppurativa

10 Jun 2026

Adverse reproductive factors plus unhealthy lifestyle tied to higher risk of cognitive decline

09 Jun 2026

In Chinese postmenopausal women, adverse reproductive factors combined with unhealthy lifestyle behaviours appear to be associated with increased likelihood of cognitive decline, as reported in a study.

Adverse reproductive factors plus unhealthy lifestyle tied to higher risk of cognitive decline

09 Jun 2026

Tezepelumab cuts oral corticosteroid use without compromising asthma control

09 Jun 2026 by

Tezepelumab demonstrates steroid-sparing potential in patients with severe asthma, reducing maintenance oral corticosteroid use while maintaining asthma control, as shown in the phase III SUNRISE study.

Tezepelumab cuts oral corticosteroid use without compromising asthma control

09 Jun 2026

Early CKD screening in CAD patients must include eGFR, UACR: study

09 Jun 2026

A recent study has emphasized the importance of early screening for chronic kidney disease (CKD) among patients with coronary artery disease (CAD). Both estimated glomerular filtration rate (eGFR) and urinary albumin/creatinine ratio (UACR) must be included in the test to provide a complete diagnosis.

Early CKD screening in CAD patients must include eGFR, UACR: study

09 Jun 2026

Rapid response to obesity medications tied to greater weight loss

09 Jun 2026 by

A post hoc analysis of the SURMOUNT-5 study reveals more tirzepatide-treated individuals with obesity achieving all body weight (BW) reduction thresholds than semaglutide-treated participants, with rapid responders showing a greater magnitude of weight loss.

Rapid response to obesity medications tied to greater weight loss

09 Jun 2026

Healthy low-carb, low-fat diets may lower CHD risk

09 Jun 2026

The healthy versions of low-carbohydrate (LCD) and low-fat diets (LFD) appear to reduce the risk of coronary heart disease (CHD), suggests a study.

Healthy low-carb, low-fat diets may lower CHD risk

09 Jun 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Rheumatology patients must undergo screening for anxiety, depression, FM: study

Rheumatology patients must undergo screening for anxiety, depression, FM: study

Heavy alcohol consumption raises CRC risk

Heavy alcohol consumption raises CRC risk

TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients

TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients

LNF-based regimens may alter trajectory of CHD treatment

LNF-based regimens may alter trajectory of CHD treatment

Lutikizumab shows promise in refractory hidradenitis suppurativa

Lutikizumab shows promise in refractory hidradenitis suppurativa

Adverse reproductive factors plus unhealthy lifestyle tied to higher risk of cognitive decline

Adverse reproductive factors plus unhealthy lifestyle tied to higher risk of cognitive decline

Tezepelumab cuts oral corticosteroid use without compromising asthma control

Tezepelumab cuts oral corticosteroid use without compromising asthma control

Early CKD screening in CAD patients must include eGFR, UACR: study

Early CKD screening in CAD patients must include eGFR, UACR: study

Rapid response to obesity medications tied to greater weight loss

Rapid response to obesity medications tied to greater weight loss

Healthy low-carb, low-fat diets may lower CHD risk

Healthy low-carb, low-fat diets may lower CHD risk